RU94003765A - Method for predicting recidivation of polyp formation and large intestine carcinoma after performing polypectomy - Google Patents

Method for predicting recidivation of polyp formation and large intestine carcinoma after performing polypectomy

Info

Publication number
RU94003765A
RU94003765A RU94003765/14A RU94003765A RU94003765A RU 94003765 A RU94003765 A RU 94003765A RU 94003765/14 A RU94003765/14 A RU 94003765/14A RU 94003765 A RU94003765 A RU 94003765A RU 94003765 A RU94003765 A RU 94003765A
Authority
RU
Russia
Prior art keywords
recidivation
predicting
large intestine
polypectomy
polyp formation
Prior art date
Application number
RU94003765/14A
Other languages
Russian (ru)
Other versions
RU2085951C1 (en
Inventor
Б.С. Троицкий
Original Assignee
Б.С. Троицкий
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Б.С. Троицкий filed Critical Б.С. Троицкий
Priority to RU94003765A priority Critical patent/RU2085951C1/en
Publication of RU94003765A publication Critical patent/RU94003765A/en
Application granted granted Critical
Publication of RU2085951C1 publication Critical patent/RU2085951C1/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FIELD: medicine. SUBSTANCE: method involves measuring maximum change in acid production. Its value being 5 mmole/h and lower, recidivation and metachronous tumors are to be predicted. EFFECT: enhanced accuracy of prognosis.

Claims (1)

Цель изобретения - раннее выявление и лечение рецидивных и метахронных опухолей толстой кишки. Сущность способа заключается в том, что возникновение рецидивов полипообразования и рака толстой кишки после полипэктомии определяют по изменению уровня максимальной кислотной продукции желудка. При ее значении 5 ммоль/ч и ниже прогнозируют развитие рецидивных и метахронных опухолей.The purpose of the invention is the early detection and treatment of recurrent and metachronous colon tumors. The essence of the method lies in the fact that the occurrence of relapses of polypo formation and colon cancer after polypectomy is determined by the change in the level of maximum acid production of the stomach. With its value of 5 mmol / h and below, the development of recurrent and metachronous tumors is predicted.
RU94003765A 1994-02-03 1994-02-03 Method for prognosticating relapses of polyp formation and large intestine cancer after polypectomy RU2085951C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94003765A RU2085951C1 (en) 1994-02-03 1994-02-03 Method for prognosticating relapses of polyp formation and large intestine cancer after polypectomy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94003765A RU2085951C1 (en) 1994-02-03 1994-02-03 Method for prognosticating relapses of polyp formation and large intestine cancer after polypectomy

Publications (2)

Publication Number Publication Date
RU94003765A true RU94003765A (en) 1996-08-10
RU2085951C1 RU2085951C1 (en) 1997-07-27

Family

ID=20152051

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94003765A RU2085951C1 (en) 1994-02-03 1994-02-03 Method for prognosticating relapses of polyp formation and large intestine cancer after polypectomy

Country Status (1)

Country Link
RU (1) RU2085951C1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2454176C1 (en) * 2011-01-14 2012-06-27 Государственное учреждение здравоохранения Научно-исследовательский институт скорой помощи имени Н.В. Склифосовского Департамента здравоохранения г. Москвы Method of predicting relapse-free survival of patients with colorectal cancer metastases in liver after its resection

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2447447C1 (en) * 2010-08-03 2012-04-10 Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Федерального агентства по высокотехнологичной медицинской помощи" Method for prediction of developing metachronous colon cancer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2454176C1 (en) * 2011-01-14 2012-06-27 Государственное учреждение здравоохранения Научно-исследовательский институт скорой помощи имени Н.В. Склифосовского Департамента здравоохранения г. Москвы Method of predicting relapse-free survival of patients with colorectal cancer metastases in liver after its resection

Also Published As

Publication number Publication date
RU2085951C1 (en) 1997-07-27

Similar Documents

Publication Publication Date Title
Zhang et al. MicroRNAs in serum exosomes as potential biomarkers in clear-cell renal cell carcinoma
Patai et al. Serrated pathway: alternative route to colorectal cancer
Ahmed et al. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer
Ding et al. Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma
Liu et al. Correlation of TNFAIP8 overexpression with the proliferation, metastasis, and disease-free survival in endometrial cancer
SG145559A1 (en) Genes and polypeptides relating to human colon cancers
Liang et al. Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors
Lu et al. Reduced expression of SRY-box containing gene 17 correlates with an unfavorable melanoma patient survival
Cavia-Saiz et al. The role of plasma IDO activity as a diagnostic marker of patients with colorectal cancer
De Chiara et al. Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients
Dourmishev et al. Paraneoplastic dermatological manifestation of gastrointestinal malignancies
DE69825431D1 (en) DIAGNOSTICS FOR EARLY DETECTION OF STOMACH CANCER
Wu et al. The gastric fluid proteome as a potential source of gastric cancer biomarkers
Yang et al. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer
Wu et al. Serum levels and positive rates of tumor biomarkers in oral precancer patients
Mikhaleva et al. Bladder cancer: update on risk factors, molecular and ultrastructural patterns
RU94003765A (en) Method for predicting recidivation of polyp formation and large intestine carcinoma after performing polypectomy
Shukla et al. Genetic changes of P 53 and Kras in gallbladder carcinoma in Kumaon region of Uttarakhand
Jiang et al. Identification of candidate biomarkers that involved in the epigenetic transcriptional regulation for detection gastric cancer by iTRAQ based quantitative proteomic analysis
Ohe et al. Chromophobe renal cell carcinoma with neuroendocrine differentiation/morphology: a clinicopathological and genetic study of three cases
Moety et al. Lipocalin: a novel diagnostic marker for hepatocellular carcinoma in chronic liver disease patients in Egypt
Zhang et al. Identification of potential biomarkers for digestive system cancers from serum-derived extracellular vesicle RNA
Xie et al. Down-regulation of C12orf59 is associated with a poor prognosis and VHL mutations in renal cell carcinoma
Hirano et al. Altered expression of p53 and p27 proteins, alone or combined, as a predictor of metastatic potential in early invasive carcinoma of colon and rectum--a comparative clinicopathologic and molecular analysis
Tsoneva et al. Liquid Liver Biopsy for Disease Diagnosis and Prognosis